Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

IMUX US Equity

Immunic, Inc.Health Care · Pharmaceutical Preparations · CIK 1280776 · FY ends Dec 31
$16.45
-0.45 (-2.66%)
USD · as of 2026-08-19 · marketstack
3 8-K filings · 0 13D · 7 13G
DateEventWhat happened / filerSource
2026-08-1413GSchedule 13G filed — ≥5% beneficial owner (passive) · by ORBIMED ADVISORS LLCsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Nantahala Capital Management, LLCsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Commodore Capital LPsec.gov ↗
2026-08-1313G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Soleus Capital Master Fund, L.P.sec.gov ↗
2026-08-118-K 7.01Regulation FD disclosuresec.gov ↗
2026-08-118-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-08-118-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-0713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by INTEGRATED CORE STRATEGIES (US) LLCsec.gov ↗
2026-08-0413GSchedule 13G filed — ≥5% beneficial owner (passive) · by Laurion Capital Management LPsec.gov ↗
2026-07-1613G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Aberdeen Group plcsec.gov ↗
2026-07-148-K 7.01Regulation FD disclosuresec.gov ↗
2026-07-068-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-06

Every row is a filed document, checked against its EDGAR index.